FIGO position statement on opportunistic salpingectomy as an ovarian cancer prevention strategy
Issued Date
2024-01-01
Resource Type
ISSN
00207292
eISSN
18793479
Scopus ID
2-s2.0-85206700068
Pubmed ID
39412638
Journal Title
International Journal of Gynecology and Obstetrics
Rights Holder(s)
SCOPUS
Bibliographic Citation
International Journal of Gynecology and Obstetrics (2024)
Suggested Citation
Mor-Hadar D., Wilailak S., Berek J., McNally O.M., Wilailak S., Berek J., Fotopoulou C., Cain J., Pareja R., Schmalfeldt B., Scambia G., Anorlu R., Marshall A., Garello N., Ruzindana K., Ramirez Y., McNally O.M., Matias-Guiu X., Yanaihara N., Concin N. FIGO position statement on opportunistic salpingectomy as an ovarian cancer prevention strategy. International Journal of Gynecology and Obstetrics (2024). doi:10.1002/ijgo.15884 Retrieved from: https://repository.li.mahidol.ac.th/handle/20.500.14594/101758
Title
FIGO position statement on opportunistic salpingectomy as an ovarian cancer prevention strategy
Corresponding Author(s)
Other Contributor(s)
Abstract
Epithelial ovarian cancer, with the highest mortality rate among gynecologic malignancies, often goes undetected until advanced stages due to non-specific symptoms. Traditional prevention strategies such as bilateral salpingo-oophorectomy (BSO) are limited to high-risk women and induce surgical menopause, often leading to significant health concerns. Recent findings suggest that many serous epithelial ovarian cancers originate in the fallopian tubes rather than the ovaries. This has led to the hypothesis that salpingectomy, with preservation of the ovaries, may reduce the risk of ovarian cancer while avoiding the adverse effects of early menopause. Studies show that bilateral salpingectomy (BS) significantly reduces ovarian cancer incidence even in average-risk women. Bilateral salpingectomy has been demonstrated to be safe with minimal added operative time, no adverse effects on ovarian function and is also cost effective. Opportunistic salpingectomy (OS), at the time of non-gynecologic surgeries, is a promising strategy for reducing ovarian cancer risk, especially among average-risk women who have completed childbearing. It offers a safe and cost-effective alternative to traditional methods. Emerging data supports incorporating OS into standard surgical practices for benign gynecologic conditions and considering it during unrelated abdominal/pelvic surgeries after adequate patient counseling and informed consent. Further training of non-gynecologic surgeons in OS is recommended to expand its preventive benefits.